The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-(2-Octylhydrazine-1-carbonyl)benzyl)benzamide ID: ALA4755760
PubChem CID: 139558716
Max Phase: Preclinical
Molecular Formula: C23H31N3O2
Molecular Weight: 381.52
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCCCNNC(=O)c1ccc(CNC(=O)c2ccccc2)cc1
Standard InChI: InChI=1S/C23H31N3O2/c1-2-3-4-5-6-10-17-25-26-23(28)21-15-13-19(14-16-21)18-24-22(27)20-11-8-7-9-12-20/h7-9,11-16,25H,2-6,10,17-18H2,1H3,(H,24,27)(H,26,28)
Standard InChI Key: ZKPWJMVLLYKMKH-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 29 0 0 0 0 0 0 0 0999 V2000
9.4248 -15.3230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7194 -14.9151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7186 -14.0979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0091 -13.6900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3004 -14.0993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3013 -14.9165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0108 -15.3244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4256 -16.1402 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1335 -14.9137 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8389 -15.3216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5475 -14.9123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2570 -15.3243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9616 -14.9150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9608 -14.0978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2554 -13.6899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5467 -14.0951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6695 -13.6885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6686 -12.8713 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.3790 -14.0964 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0876 -13.6871 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0868 -12.8699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7914 -12.4606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7947 -11.6434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4992 -11.2341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4984 -10.4169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2071 -10.0076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2063 -9.1904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9150 -8.7811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
2 7 2 0
1 8 2 0
1 9 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
11 16 2 0
17 18 2 0
19 20 1 0
17 19 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
20 21 1 0
14 17 1 0
9 10 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 381.52Molecular Weight (Monoisotopic): 381.2416AlogP: 4.21#Rotatable Bonds: 12Polar Surface Area: 70.23Molecular Species: NEUTRALHBA: 3HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.90CX LogP: 4.65CX LogD: 4.65Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.38Np Likeness Score: -0.83
References 1. McClure JJ,Zhang C,Inks ES,Peterson YK,Li J,Chou CJ. (2016) Development of Allosteric Hydrazide-Containing Class I Histone Deacetylase Inhibitors for Use in Acute Myeloid Leukemia., 59 (21): [PMID:27754681 ] [10.1021/acs.jmedchem.6b01385 ]